[Transposition of the left upper pulmonary vein with atresia of the coronary sinus].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F Bender.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
1 The effects of a single oral dose of 5 mg pindolol (P) and 100 mg metoprolol (M) were assessed in a double-blind study in 30 patients undergoing oral surgery. 2 Systolic and diastolic blood pressures and heart rate were reduced 90 min after oral medication and did not exceed initial values at rest during the procedure. 3 Noradrenaline, adrenaline and c-AMP concentrations did not differ at any time from the control values at rest after P, but were increased after local anaesthesia and during oral surgery after M as were the metabolic responses reflected by plasma concentrations of glucose and free-fatty acids. 4 Plasma levels of ACTH and cortisol showed the typical increase during the procedure, being independent of beta-adrenoceptor blockade. In contrast to the cardioselective antagonist M, prophylactic administration of the non-selective drug P prevented the sympathetic and metabolic responses to the stress of oral surgery. 5 Hypothalamic and adrenal stimulation were not reduced by either selective or non-selective beta-adrenoceptor blockade.
37 patients with either chronic atrial fibrillation (AF), atrial premature beats (APBs) or ventricular premature beats (VPBs) received tiapamil as antiarrhythmic treatment. Tiapamil reduced A-V conduction by an average 20% in the group with AF (10 patients), the magnitude of response being dependent on the initial ventricular rate. In 3 of the 7 patients with APBs, the frequency of ectopic beats was reduced following a single i.v. injection of 1 mg/kg tiapamil. In patients with VPBs (n = 20), tiapamil (i.v. injection of 1 mg/kg followed by 4-hour i.v. infusion of 50 micrograms/kg/min in 10 patients) reduced ectopic beats by 30-50% in 6 cases, these all being patients who had not responded to previous antiarrhythmic therapy. The antiarrhythmic effect was maintained by i.v. infusion of 50 micrograms/kg/min for 4 h. The antiarrhythmic effect of tiapamil consists essentially in slowing A-V conduction and reducing chronic VPBs.
Age dependent decrease of heart rate in sinus rhythm at rest was shown under clinical and experimental conditions and correlated with a decrease of sympathetic storage granula and membranes indicated by the tissue concentrations of c-AMP, which can be regarded as a messenger at the receptor sites. A slower maximal heart rate after Atropine and a reduced increase during oral medication with Ipratropium bromide can be explained by a reduced cardiac sympathetic threshold. The mentioned age dependent differences of the sympathetic stimulation can not be deduced to myocardial changes, because CPK and CK-MB activities were similar in the different age groups.
We reported recently that in patients suffering from atrial fibrillation and being refractory to antifibrillatory therapy with quinidine conversion to sinus rhythm can often be achieved by additional doses of verapamil. To further evaluate the mechanism of this drug interaction, we studied the effects of quinidine, verapamil and combined quinidine-verapamil on the thresholds for electrically induced atrial repetitive extrasystoles (RET) and fibrillation (AFT). Comparative investigations were performed using the new calcium antagonist diltiazem. Our results show that verapamil provides protection against electrically induced atrial reentry arrhythmias only in combination with quinidine, but fails to exert a protective action when given alone. The increased success rate of conversion to sinus rhythm following combined quinidine-verapamil in patients with atrial fibrillation can be explained by an increase in the RET and AFT. The basic mechanism of this effect is supposed to be due to antiadrenergic properties of verapamil. In contrast to verapamil, diltiazen lacks the ability to increase RET and AFT in the presence of quinidine; diltiazen therefore cannot be expected to increase the antifibrillatory efficacy of quinidine in patients with atrial fibrillation.
The management of septicemia associated with an infected endocardial pacemaker lead prerequisites removal of the latter nidus. If the infected electrode cannot be manually withdrawn, continuous traction may be employed. Should this attempted fail or should the severed end of the electrode fragment be inaccessible to a superficial approach, thoracotomy may be necessary. As an alternative procedure, we have successfully removed infected electrode fragments from three patients with septicemia by use of a Dotter retrieval catheter monitored with biplane fluoroscopy. The septicemia was subsequently irradiated in all cases.
Explore the source record for details and available documents.
215 out-patients aged between 65 and 88 years (average age 70.3 years) were examined radiologically for coronary calcification. In 62.5% of the cases positive results were obtained with a prevalence of men over women. From the 134 patients with coronary calcification 81.5% had a pathological ECG and 32% of these showed evidence of transmural infarction. The combination of coronary calcification and chronic arterial hypertension was found in 68.5% of the patients. In our opinion radioscopy of the heart for the detection of coronary calcification is of particular diagnostic value, on account of its safety and simplicity, especially with elderly patients; all the more so since the otherwise usual diagnostic techniques such as ergometry and selective coronary angiography can, for reasons of age, only be performed in certain cases.
Explore the source record for details and available documents.
The present study was undertaken in order to obtain further informations on non-beta-antiadrenergic properties of the four beta-sympatholytic agents acebutolol, oxprenolol, pindolol, and propranolol. Standardized experiments were performed using a chronically reserpinized canine preparation for the assessment of dose-response curves of changes in hemodynamics, left ventricular contractility, heart rate, AV-conduction time, and myocardial oxygen consumption especially at therapeutic doses. Our results show that acebutolol and oxprenolol, at doses clinically recommended, exert moderate positive inotropic effects but do not influence heart rate significantly. Pindolol has a strong both positive chronotropic and inotropic efficacy, even at small therapeutic doses. Propranolol produces neither chronotropic nor inotropic effects. In contrast to the literature acebutolol exerts direct cardiodepression at doses clinically used, whereas oxprenolol, pindolol, at propranolol have no direct cardiodepressant properties at those doses. Thus the relationship between the dose requirements for chronotropic and inotropic sympathomimetic effects differs for each beta-sympatholytic agents, and in may prove impossible to get an order of intrinsic sympathomimetic potency of beta-blockers comparing dose-response curves of heart rate changes only. As shown in the case of acebutolol, direct cardiodepression of beta-sympatholytic agents may occur at therapeutic doses.
In two studies including 73 patients the stress reducing effects of the tranquilizer Cloxazolam (Olcadil) and the beta-receptor-blocking drug pindolol (Visken) were investigated after the application of a single oral dose (3 mg Cloxazolam, 5 mg pindolol). The drugs were tested against placebo by the double blind method. After local anesthesia and during oral surgery an increase of dopamine-beta-hydroxylase (DBH)-activity, noradrenaline-, c-AMP-, ACTH and cortisol concentration was found in the placebo group. Cloxazolam antagonized all these effects, except the increase of the plasma levels of c-GMP under surgical stress. After pindolol noradrenaline concentration, DBH-activity, and c-AMP concentration were no longer increased during oral surgery. But the hypothalamic and adrenal stimulation were still present and resulted in an unchanged stress reaction of ACTH and cortisol concentration in plasma. In conclusion, the application of the beta-receptor-blocking drug pindolol prevents the stimulation of the sympathetic nervous system by suppressing the stress induced increase of plasma system by suppressing the stress induced increase of plasma noradrenaline and by blockade of peripheral beta-receptor sites. Cloxazolam reduces hypothalamic and adrenal reaction as well as peripheral ones due to stress.
Clinical and experimental studies indicate that ventricular arrhythmias, especially ventricular fibrillation, are in almost all cases the mechanism for sudden death occurring during the first 24 hours after the onset of an ischaemic myocardial event. Therefore a higher survival rate seems to depend on advances in antiarrhythmic therapy. The present study investigates the efficacy of the new local anaesthetic compound Flecainide in reducing or preventing ventricular arrhythmias and primary ventricular fibrillation, using a standardized experimental canine preparation. Our findings demonstrate that ventricular arrhythmias due to severe transmural myocardial infarction are reduced by 80-90% following the application of Flecainide. In some cases a complete abolition of the arrhythmias can be observed. The striking reduction in ventricular ectopics includes decreases in ventricular salves and R-on-T phenomena, which may lead to sudden death by precipitating ventricular fibrillation. The beneficial antiarrhythmic and antifibrillatory actions of Flecainide affect only the arrhythmias resulting from transmural necrosis of the myocardium ("in-hospital arrhythmias", 2nd-phase arrhythmias"), whereas the incidence of early ventricular arrhythmias, especially ventricular fibrillation occurring in the very inception of myocardial ischaemia ("pre-hospital arrhythmias", "1st-phase arrhythmias") is not prevented. Changes in hemodynamics and contractility due to Flecainide are not severe, even in myocardial infarction. Thus, our results indicate that the application of Flecainide in acute myocardial infarction in man may be successful in reducing therapy-resistant ventricular dysrhythmias.
The bioequivalence of subcutaneous porcine calcium and sodium heparins was studied in 48 normal male subjects randomly assigned to 1 of 4 study groups. Each subject received a single subcutaneous injection of 15,000 U of calcium heparin or 1 of 3 sodium heparins. Serial coagulation studies (Lee-White clotting time, activated partial thromboplastin time, thrombin calcium clotting time, and heparin level) were performed over 10 hr. There were no significant differences in anticoagulant effect between groups.